Cargando…

Bioinformatic identification of previously unrecognized amyloidogenic proteins

Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intri...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenberg, Gregory M., Murray, Kevin A., Salwinski, Lukasz, Hughes, Michael P., Abskharon, Romany, Eisenberg, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108986/
https://www.ncbi.nlm.nih.gov/pubmed/35405097
http://dx.doi.org/10.1016/j.jbc.2022.101920
_version_ 1784708821796519936
author Rosenberg, Gregory M.
Murray, Kevin A.
Salwinski, Lukasz
Hughes, Michael P.
Abskharon, Romany
Eisenberg, David S.
author_facet Rosenberg, Gregory M.
Murray, Kevin A.
Salwinski, Lukasz
Hughes, Michael P.
Abskharon, Romany
Eisenberg, David S.
author_sort Rosenberg, Gregory M.
collection PubMed
description Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intrinsically disordered and function in self-association. The question therefore arises whether a search for pathogenic mutations in LCDs of the human proteome can lead to identification of other proteins associated with amyloid disease. Here, we take a computational approach to identify documented pathogenic mutations within LCDs that may favor amyloid formation. Using this approach, we identify numerous known amyloidogenic mutations, including several such mutations within proteins previously unidentified as amyloidogenic. Among the latter group, we focus on two mutations within the TRK-fused gene protein (TFG), known to play roles in protein secretion and innate immunity, which are associated with two different peripheral neuropathies. We show that both mutations increase the propensity of TFG to form amyloid fibrils. We therefore conclude that TFG is a novel amyloid protein and propose that the diseases associated with its mutant forms may be amyloidoses.
format Online
Article
Text
id pubmed-9108986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-91089862022-05-20 Bioinformatic identification of previously unrecognized amyloidogenic proteins Rosenberg, Gregory M. Murray, Kevin A. Salwinski, Lukasz Hughes, Michael P. Abskharon, Romany Eisenberg, David S. J Biol Chem Research Article Low-complexity domains (LCDs) of proteins have been shown to self-associate, and pathogenic mutations within these domains often drive the proteins into amyloid aggregation associated with disease. These domains may be especially susceptible to amyloidogenic mutations because they are commonly intrinsically disordered and function in self-association. The question therefore arises whether a search for pathogenic mutations in LCDs of the human proteome can lead to identification of other proteins associated with amyloid disease. Here, we take a computational approach to identify documented pathogenic mutations within LCDs that may favor amyloid formation. Using this approach, we identify numerous known amyloidogenic mutations, including several such mutations within proteins previously unidentified as amyloidogenic. Among the latter group, we focus on two mutations within the TRK-fused gene protein (TFG), known to play roles in protein secretion and innate immunity, which are associated with two different peripheral neuropathies. We show that both mutations increase the propensity of TFG to form amyloid fibrils. We therefore conclude that TFG is a novel amyloid protein and propose that the diseases associated with its mutant forms may be amyloidoses. American Society for Biochemistry and Molecular Biology 2022-04-09 /pmc/articles/PMC9108986/ /pubmed/35405097 http://dx.doi.org/10.1016/j.jbc.2022.101920 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Rosenberg, Gregory M.
Murray, Kevin A.
Salwinski, Lukasz
Hughes, Michael P.
Abskharon, Romany
Eisenberg, David S.
Bioinformatic identification of previously unrecognized amyloidogenic proteins
title Bioinformatic identification of previously unrecognized amyloidogenic proteins
title_full Bioinformatic identification of previously unrecognized amyloidogenic proteins
title_fullStr Bioinformatic identification of previously unrecognized amyloidogenic proteins
title_full_unstemmed Bioinformatic identification of previously unrecognized amyloidogenic proteins
title_short Bioinformatic identification of previously unrecognized amyloidogenic proteins
title_sort bioinformatic identification of previously unrecognized amyloidogenic proteins
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108986/
https://www.ncbi.nlm.nih.gov/pubmed/35405097
http://dx.doi.org/10.1016/j.jbc.2022.101920
work_keys_str_mv AT rosenberggregorym bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins
AT murraykevina bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins
AT salwinskilukasz bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins
AT hughesmichaelp bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins
AT abskharonromany bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins
AT eisenbergdavids bioinformaticidentificationofpreviouslyunrecognizedamyloidogenicproteins